Protection by almagate of ethanol-induced gastric mucosal damage in rats. 1995

J V Esplugues, and M D Barrachina, and M A Martínez-Cuesta, and S Calatayud, and L Moreno, and A Fernandez, and J Puig, and J Esplugues
Department of Pharmacology, Faculty of Medicine, University of Valencia, Spain.

The study was designed to analyse the protective effects of almagate on a model of gastric injury, ethanol-induced mucosal damage, in which acid plays little, if any, role. Pretreatment with almagate dose-dependently reduced the level of gastric damage induced by oral administration of 1 mL 100% ethanol. Administration of 12 mumol kg-1 alamagate 30 min before ethanol significantly reduced the area of mucosal damage by 65 +/- 10%, and the maximum level of inhibition (74 +/- 11%) was obtained with 150 mumol kg-1 almagate. Administration of higher doses of almagate (200-250 mumol kg-1) did not result in any further increase in the level of protection against ethanol-induced gastric damage. Administration of 1 mL 100% ethanol induces substantial damage to the gastric mucosa, with nearly 40% of the length of the section evaluated exhibiting deep necrotic and haemorrhagic damage. Pretreatment with almagate caused a significant diminution in all parameters of histological damage, whereas damage to the epithelial cell layer was only significantly reduced by pretreatment with the highest doses evaluated (25, 50 and 150 mumol kg-1). Administration of aluminium hydroxide did not modify ethanol-induced mucosal damage, even at doses containing concentrations of aluminium higher than those present in gastroprotective doses of almagate. Pretreatment with sucralfate, another aluminium containing compound, at doses of 250 mumol kg-1 protected the mucosa, although lower doses did not. The present study has shown that almagate prevents ethanol-induced gastric mucosal damage.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D008276 Magnesium Hydroxide An inorganic compound that occurs in nature as the mineral brucite. It acts as an antacid with cathartic effects. Brucite,Magnesium Hydrate,Magnesium Hydroxide (Mg(OH)4),Hydrate, Magnesium,Hydroxide, Magnesium
D008297 Male Males
D002254 Carbonates Salts or ions of the theoretical carbonic acid, containing the radical CO2(3-). Carbonates are readily decomposed by acids. The carbonates of the alkali metals are water-soluble; all others are insoluble. (From Grant & Hackh's Chemical Dictionary, 5th ed) Carbonate
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D005753 Gastric Mucosa Lining of the STOMACH, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. The surface cells produce MUCUS that protects the stomach from attack by digestive acid and enzymes. When the epithelium invaginates into the LAMINA PROPRIA at various region of the stomach (CARDIA; GASTRIC FUNDUS; and PYLORUS), different tubular gastric glands are formed. These glands consist of cells that secrete mucus, enzymes, HYDROCHLORIC ACID, or hormones. Cardiac Glands,Gastric Glands,Pyloric Glands,Cardiac Gland,Gastric Gland,Gastric Mucosas,Gland, Cardiac,Gland, Gastric,Gland, Pyloric,Glands, Cardiac,Glands, Gastric,Glands, Pyloric,Mucosa, Gastric,Mucosas, Gastric,Pyloric Gland
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000431 Ethanol A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES. Alcohol, Ethyl,Absolute Alcohol,Grain Alcohol,Alcohol, Absolute,Alcohol, Grain,Ethyl Alcohol

Related Publications

J V Esplugues, and M D Barrachina, and M A Martínez-Cuesta, and S Calatayud, and L Moreno, and A Fernandez, and J Puig, and J Esplugues
January 1991, Pharmacological research,
J V Esplugues, and M D Barrachina, and M A Martínez-Cuesta, and S Calatayud, and L Moreno, and A Fernandez, and J Puig, and J Esplugues
December 1995, Pharmacology,
J V Esplugues, and M D Barrachina, and M A Martínez-Cuesta, and S Calatayud, and L Moreno, and A Fernandez, and J Puig, and J Esplugues
July 2013, Life sciences,
J V Esplugues, and M D Barrachina, and M A Martínez-Cuesta, and S Calatayud, and L Moreno, and A Fernandez, and J Puig, and J Esplugues
January 1987, Zhen ci yan jiu = Acupuncture research,
J V Esplugues, and M D Barrachina, and M A Martínez-Cuesta, and S Calatayud, and L Moreno, and A Fernandez, and J Puig, and J Esplugues
January 1979, Scandinavian journal of gastroenterology,
J V Esplugues, and M D Barrachina, and M A Martínez-Cuesta, and S Calatayud, and L Moreno, and A Fernandez, and J Puig, and J Esplugues
April 1992, Digestive diseases and sciences,
J V Esplugues, and M D Barrachina, and M A Martínez-Cuesta, and S Calatayud, and L Moreno, and A Fernandez, and J Puig, and J Esplugues
July 1988, The Journal of pharmacy and pharmacology,
J V Esplugues, and M D Barrachina, and M A Martínez-Cuesta, and S Calatayud, and L Moreno, and A Fernandez, and J Puig, and J Esplugues
February 1986, Digestive diseases and sciences,
J V Esplugues, and M D Barrachina, and M A Martínez-Cuesta, and S Calatayud, and L Moreno, and A Fernandez, and J Puig, and J Esplugues
January 1991, Pharmacology,
J V Esplugues, and M D Barrachina, and M A Martínez-Cuesta, and S Calatayud, and L Moreno, and A Fernandez, and J Puig, and J Esplugues
January 1996, Digestive diseases and sciences,
Copied contents to your clipboard!